When clinical trials were conducted to determine the immunogenicity -- the ability to elicit an immune response -- for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among those included: people who have received solid organ transplants and others (such as those with autoimmune disorders) who are immunocompromised.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/03/210324170811.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/03/210324170811.htm
COVID-19 vaccines may not produce sufficient antibody response in transplant recipients
![COVID-19 vaccines may not produce sufficient antibody response in transplant recipients]()
Reviewed by cmakigo
on
March 25, 2021
Rating:
No comments:
Post a Comment